Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nerve Repair Using Hydrophilic Polymers (PEG) for Peripheral Nerve Injuries
NCT02359825Phase 1Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Sep 2019
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of polyethylene glycol in peripheral nerve injury (PNI) (6 arms), sponsored by Vanderbilt University Medical Center. Primary endpoint: Medical Research Council Classification at 12 months. Started Sep 2019; status: completed.
02
Drugs
polyethylene glycol
03
Conditions
peripheral nerve injury (PNI)
Beyond the preview
Go deeper on NCT02359825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359825.